Kuhadiya, Nitesh D <br/><br/>
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  04 2019 
 - 1054-1057 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.13609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Autoantibodies--immunology<br/>Body Weight<br/>C-Peptide--metabolism<br/>Deprescriptions<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Glucagon-Like Peptides--analogs & derivatives<br/>Glutamate Decarboxylase--immunology<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Immunoglobulin Fc Fragments--therapeutic use<br/>Insulin--therapeutic use<br/>Liraglutide--therapeutic use<br/>Male<br/>Middle Aged<br/>Recombinant Fusion Proteins--therapeutic use<br/>Retrospective Studies<br/>Treatment Outcome<br/>Weight Loss<br/>Glucagon-Like Peptide-1 Receptor Agonists